Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer

Digestive Surgery

Volumn 29, Issue 6, 2012, Pages 503-509

  Sugimoto, Kiichi ^a   Komiyama, Hiromitsu ^a   Kojima, Yutaka ^a   Goto, Michitoshi ^a   Tomiki, Yuichi ^a   Sakamoto, Kazuhiro ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C reactive protein; Colorectal cancer; Glasgow Prognostic Score; Hypoalbuminemia; Inflammation; Prognostic factor

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; COLON RESECTION; COLORECTAL TUMOR; DECISION SUPPORT SYSTEM; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HYPOALBUMINEMIA; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; RECTUM; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COLECTOMY; COLORECTAL NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOALBUMINEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RECTUM; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84873390834     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000346002     Document Type: Article

References (20)

1. Kayama T, Wakao F, Sobue T, Katanoda K, Tsukuma H, Mikami H, Kitai A: Cancer statistics in Japan-2011. Tokyo, Foundation for Promotion of Cancer Research, 2011.
2. McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007; 22: 881-886. (Pubitemid 46952036)
3. Graziano F, Cascinu S: Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann Oncol 2003; 14:1026-1038. (Pubitemid 36950166)
4. Longo WE, Virgo KS, Johnson FE, Wade TP, Vernava AM, Phelan MA, Henderson WG, Daley J, Khuri SF: Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program. Ann Surg 1998; 228:64-70. (Pubitemid 30190317)
5. Heys SD, Walker LG, Deehan DJ, Eremin OE: Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 1998; 43:163-168. (Pubitemid 28306032)
6. Longo WE, Virgo KS, Johnson FE, Oprian CA, Vernava AM, Wade TP, Phelan MA, Henderson WG, Daley J, Khuri SF: Risk factors for morbidity and mortality after colec-tomy for colon cancer. Dis Colon Rectum 2000; 43:83-91. (Pubitemid 30056668)
7. Nozoe T, Matsumata T, Kitamura M, Sugimachi K: Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998; 176:335-338. (Pubitemid 28514444)
8. Nielsen HJ, Christensen IJ, Sorensen S, Moesgaard F, Brunner N: Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol 2000; 7:617-623.
9. McMillan DC, Canna K, McArdle CS: Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 2003; 90:215-219. (Pubitemid 36237897)
10. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K: Inflammationbased prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 2007; 246:1047-1051. (Pubitemid 350179198)
11. Ishizuka M, Kita J, Shimoda M, Rokkaku K, Kato M, Sawada T, Kubota K: Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol 2009; 100:38-42.
12. Sobin LH, Gospodarowicz MK, Wittekind Ch: TNM Classification of Malignant Tumours, ed 7. New York, Wiley-Blackwell, 2009, pp 100-105.
13. Ishizuka M, Nagata H, Takagi K, Kubota K: Systemic inflammatory response Associated with distant metastasis of T1 or T2 colorectal cancer. Dig Dis Sci 2010; 55:3181-3187.
14. Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545. (Pubitemid 32173595)
15. ten Kate M, Holfland LJ, van Koetsveld PM, Johannes J, van Eijck CHJ: Proinflammatory cytokines affect pancreatic carcinoma cell. Endothelial cell interactions. JOP 2006; 7: 454-464.
16. Canna K, McArdle PA, McMillan DC, McNicol AM, Smith GW, Mckee RF, McArdle CS: The relationship between tumour T-lympho-cyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 2005; 92:651-654. (Pubitemid 40460599)
17. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ: C-reactive protein and the risk of incident colorectal cancer. JAMA 2004; 291:585-590. (Pubitemid 38500312)
18. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR, Albanes D, Sinha R: A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 2006; 66:2483-2487.
19. Wong VK, Malik HZ, Hamady ZZ, Mukhtar AAI, Gomez D, Prasad KR, Toogood GJ, Lodge JPA: C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastasis. Br J Cancer 2007; 96:222-225. (Pubitemid 46160625)
20. Dixon MR, Haukoos JS, Udani SM, Naghi JJ, Arnell TD, Kumar RR, Stamos MJ: Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg 2003; 138:962-966. (Pubitemid 37099870)